Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04806568 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients With Multiple Sclerosis

Study acronym: MSNEUROPLAST
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 6 more changesShow less
    • Study completion pushed from Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria expanded, about 18 words
    • Secondary endpoints: 23 to 22
    • Study description expanded, about 15 words
    • Site details revised
    • Publications: details revised at 4 of 4 entries
  2. Interventions: Cognitive Training (Other) to Cognitive Training (Other), Monitoring of daily activity (Device)v7
  3. Site contact updatedv6
  4. Primary completion date: May 31, 2024 to Dec 31, 2025
    • Study completion date: Jun 7, 2024 to Dec 31, 2025
    • Eligibility criteria shortened, about 26 words
    • Study description revised
    v5
  5. Primary completion date: Oct 31, 2023 to May 31, 2024
    • Enrollment target: 150 to 180
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Active, Not Recruiting to Recruitingv3 Show 10 more changesShow less
    • Enrollment target: 90 to 150
    • Primary endpoints: 2 to 3
    • Primary completion date: Nov 30, 2023 to Oct 31, 2023
    • Study completion date: Nov 30, 2023 to Jun 7, 2024
    • Eligibility criteria expanded, about 73 words
    • Secondary endpoints: 2 to 23
    • Study description expanded, about 644 words
    • Study site revised
    • Study title revised
    • Study arms: 2 to 3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical study aims to identify MS related beneficial plasticity and by contrast maladaptive reorganization in combination with elements of daily functional status as a response to a cognitive training program
Trial Details
NCT Number NCT04806568
Lead Sponsor Aristotle University Of Thessaloniki
Collaborators: King Fahad Medical City
Conditions
(from sponsor)		 Multiple Sclerosis, Cognitive Decline
Related terms Cognitive Dysfunction, Multiple Sclerosis
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov